Bipolar Disorder Trial, Recruiting NCT05866107 Sponsor: Capital Medical University Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT05866107
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 60 years old, of any gender.
  • People who have been diagnosed with bipolar disorder or schizophrenia (according to ICD-10 diagnostic standards), and whose condition is currently in remission or is stable enough to participate in research.
  • People who are currently taking at least one antipsychotic or mood-stabilising medication (such as lithium, magnesium valproate, sodium valproate, or lamotrigine).
  • People who are currently overweight or obese (a body mass index of 24 kg/m² or higher) and who are willing to use a health app and smart scales as part of a weight loss program.
  • People who have completed at least a primary school level of education, are able to understand survey or questionnaire content, and can use a smartphone confidently.
  • People who understand the study and are willing to take part voluntarily, including signing a consent form.

Who may not be able to join:

  • People who plan to use other weight loss methods during the study, such as strict dieting, induced vomiting, diet pills, or weight loss surgery.
  • People who report having already lost 7% or more of their body weight in the past 6 months.
  • People who weigh more than 150 kg.
  • People whose excess weight is caused by another medical condition, such as an underactive thyroid, Cushing's syndrome, or a condition affecting the hypothalamus.
  • People who are currently pregnant, breastfeeding, less than 6 months postpartum, or who plan to become pregnant during the study period.
  • People who report experiencing heart discomfort or chest pain during physical activity or at rest.
  • People with a serious medical condition that the researchers believe could make physical activity unsafe.
  • People who are unable to walk for 30 minutes without stopping.
  • People who have circumstances that may make it difficult to follow the study protocol, such as a terminal illness, plans to relocate or travel away during the study, a history of substance abuse, or other uncontrolled or untreated medical conditions.
  • People whom the trial investigators consider unsuitable for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Le Xiao, Capital Medical University

Phone: +8613466604224

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Capital Medical University
Registry
ClinicalTrials.gov
Start date
31 October 2023
Est. completion
1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Percent weight loss; Adherence to self-monitoring

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov